April 27, 2015 -
Healthcare solutions firm Sentrian announced the Sentrian Remote Patient Intelligence platform (Sentrian RPI) is this year’s recipient of the American Telemedicine Association’s President’s Award for Innovation in Remote Health Care.
Launched in 2014, the ATA award is given each year to an organization for demonstrating advancement in telemedicine.
“We are honored to be recognized by ATA with this prestigious award,” said Sentrian CEO Dean Sawyer. “The award is validation of the importance of the work we’re undertaking with our customers in applying advanced analytics to remote biometric data streams. We believe the technology will drive significant reductions in hospitalization while increasing the efficiency of remote care teams – accomplishments that could greatly expand the efficacy and adoption of telemedicine in healthcare.”
The company’s predictive analytics platform enables healthcare payers and providers to significantly scale their use of remote biosensors for managing whole populations of patients with chronic disease.
The Sentrian RPI platform, which has not been approved for commercial distribution by the US Food & Drug Administration, is designed to detect problems in the early stages of chronically ill patients.
During this time, interventions are far less invasive, more affordable, and have a higher success rate.
The platform can be used by care managers in Medicare Advantage plans and other healthcare organizations to affordably broaden the reach and effectiveness of their disease management programs.
Sentrian will accept the award at the ATA Annual International Meeting & Trade Show, which will be held May 2-5 at the Los Angeles Convention Center.